股票行情快报：尚荣医疗（002551）12月8日主力资金净买入171.02万元

Core Viewpoint - The financial performance of Shangrong Medical (002551) shows significant declines in revenue and profit, indicating potential challenges in the medical device industry [2]. Group 1: Stock Performance - As of December 8, 2025, Shangrong Medical's stock closed at 3.92 yuan, with no change in price [1]. - The trading volume was 94,400 hands, with a total transaction value of 37.0863 million yuan [1]. - The net inflow of main funds was 1.7102 million yuan, accounting for 4.61% of the total transaction value [1]. Group 2: Financial Metrics - Shangrong Medical's total market value is 3.314 billion yuan, significantly lower than the industry average of 11.014 billion yuan, ranking 97th out of 124 [2]. - The company reported a net profit of -35.1253 million yuan, a decline of 338.5% year-on-year, ranking 111th in the industry [2]. - The gross profit margin stands at 14.35%, compared to the industry average of 51.22%, ranking 119th [2]. Group 3: Recent Financial Results - For the first three quarters of 2025, the company's main revenue was 754 million yuan, down 24.85% year-on-year [2]. - In Q3 2025, the single-quarter main revenue was 225 million yuan, a decrease of 39.25% year-on-year [2]. - The company's debt ratio is 23.31%, with investment income of 10.2049 million yuan and financial expenses of -3.7891 million yuan [2].